Epidemiological and clinical features, therapeutic strategies and outcomes in patients with hyperhaemolysis: A systematic review
Jeremy W. Jacobs(Vanderbilt University), Brian D. Adkins(University of Virginia Health System), Christopher A. Tormey(Yale University), Thomas C. Binns(Yale University), Garrett S. Booth(Vanderbilt University Medical Center), Jeanne E. Hendrickson(Emory University), Elizabeth S. Allen(University of California San Diego), Matthew S. Karafin(University of North Carolina at Chapel Hill), Laura D. Stephens(University of California San Diego), Jennifer S. Woo(City Of Hope National Medical Center)
Cited by 11
Related Papers
Clinical Practice Guidelines From the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 Convalescent Plasma
|Annals of Internal Medicine|2022|71
<scp>COVID</scp>‐19 associated with severe autoimmune hemolytic anemia
|Transfusion|2020|61
COVID-19 and Immune-Mediated RBC Destruction
|American Journal of Clinical Pathology|2021|42
Clinical and epidemiological features of paroxysmal cold hemoglobinuria: a systematic review
|Blood Advances|2023|37
Blood shortages and changes to massive transfusion protocols: Survey of hospital practices during the COVID-19 pandemic
|Transfusion and Apheresis Science|2021|33